Neurotech grants in the United States

Open

Funds early-stage testing of a novel-mechanism drug or a device for mental disorders, designed to show a dose-dependent effect on the target.

Open

Funds a feasibility phase then a testing phase for a novel-mechanism drug or a device for mental disorders, with milestones between them.

Open

Funds building animal and tissue models that behave enough like a real neurological disease to test drugs against.

Open

Funds building the assays and running the screens that find drug candidates for neurological disease — the on-ramp to NIH's Blueprint network.

Open

Funds the pharmacology and animal efficacy work that shows a neurological drug candidate is worth developing further.

Open

Funds computational tools, models and theories for understanding brain circuits, built to be shared broadly with the research community.

Open

Funds a genuinely new brain stimulation device for mental health, or a hardware or software change that substantially improves an approved one.

Open

Funds the exploratory version of next-generation brain stimulation device work for mental health, with the same floor on how much novelty counts.

Open

Funds studies using electrodes already implanted in people to record and stimulate directly, answering mental health questions no scan can reach.

Open

Funds the exploratory version of invasive human neural recording and stimulation work on mental health questions.

Open

Funds the translational and first clinical-feasibility steps for a device treating a nervous-system or neuromuscular disorder.

Scheduled

Funds building new tools to record, image or control brain cells and circuits, from first sketches to lab-ready instruments.

Between cycles

Funds translating a diagnostic or therapeutic device to the point it is ready for its first human trial, under NIH's BRAIN and HEAL initiatives.

Between cycles

Funds machine-learning and adaptive-design methods that build individual profiles, aimed at personalised prevention for cognitive and brain health.

Between cycles

Funds sensors and models that track complex behaviour and neural activity together, in real time, across species.

Between cycles

Funds team science that works out how a therapeutic medical device produces its effect, covering both approved and investigational devices.

Between cycles

Offers senior postdoctoral career acceleration for Huntington disease experts building leadership skills and independent research directions in neurobiology.

Between cycles

Funds high-risk, high-reward Friedreich ataxia research ideas with major translational upside.

Between cycles

Funds named Friedreich ataxia research programs in cardiac, translational, and collaboration areas.

Between cycles

Funds high-impact collaborative Huntington disease teams tackling complex mechanisms and novel therapeutic strategies with advanced team science.

Between cycles

Funds full projects on what genetic risk factors for brain disorders actually do inside cells, synapses and circuits.

Between cycles

Funds short, exploratory work on what genetic risk factors for brain disorders actually do inside cells and circuits.

Between cycles

Supports postdoctoral scientists building independent research careers in Huntington disease science with collaboration and translational focus.

Between cycles

Supports Huntington disease researchers pursuing creative studies and translational advances toward stronger care, biomarkers, and disease understanding.